Browse by author
Lookup NU author(s): Professor Penny Lovat,
Dr Mark Dobson,
Professor Archibald Malcolm,
Professor Andrew Pearson,
Dr Chris RedfernORCiD
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Background. 9-cis retinoic acid (RA) is more effective than all-trans RA at inducing neuroblastoma differentiation in vitro, and has distinct biological properties with respect to its ability to promote apoptosis in N-type neuroblastoma cells. The cellular effects of 9-cis RA may, in part, result from activation of retinoid X receptor (RXR) homodimers. If this hypothesis is correct, 9-cis RA may control the expression of a different subset of retinoid-regulated genes compared to all-trans RA. Procedure. We have therefore used differential mRNA display to identify genes differentially expressed in neuroblastoma cells in response to all-trans and 9-cis RA. Results. The majority of cDNAs differentially expressed in response to all-trans or 9-cis RA matched to nonredundant Genbank sequences or EST database sequences. Differential-display profiles were similar in SH SY 5Y and SH S EP cells, clonal derivatives of the mixed neuroblastoma cell line SK N SH, although there were apparent differences between these cell lines with respect to the retinoid-regulation of specific RT-PCR cDNA fragments. Conclusions. These data support the view that 9-cis and all-trans RA act via different receptor mechanisms. Med. Pediatr. Oncol. 36:135-138, 2001. (C) 2001 Wiley-Liss, Inc.
Author(s): Lovat, P.E., Dobson, M., Malcolm, A.J., Pearson, A.D.J., Redfern, C.P.F.
Publication type: Article
Publication status: Unknown
Journal: Medical and Pediatric Oncology
ISSN (print): 1545-5009
ISSN (electronic): 1545-5017
Altmetrics provided by Altmetric